Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
200
days
Targeting liver angiotensinogen with siRNA enhances podocyte regeneration through renin lineage cells in experimental kidney disease
AuthorsLoïs A.K. van der Pluijm; Angela Koudijs; A.H. Jan Danser; Joris I. Rotmans; Roel Bijkerk
AffiliationsDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, 2333ZA Leiden, the Netherlands; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, 3015GD Rotterdam, the Netherlands
278
days
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines
AuthorsJemin Kim; Soyoung Kim; Minhyuk Yoon; Seung Joon Baek; Chanseok Shin
AffiliationsDepartment of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea; Laboratory of Signal Transduction, College of Veterinary Medicine, Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul 08826, Republic of Korea; Plant Genomics and Breeding Institute, Seoul National University, Seoul 08826, Republic of Korea; Research Center for Plant Plasticity, Seoul National University, Seoul 08826, Republic of Korea
184
days
Focal ischemia induces genome-wide accumulation of R-loops in the brain
AuthorsVijay Arruri; Suresh L. Mehta; Raghu Vemuganti
AffiliationsDepartment of Neurological Surgery, University of Wisconsin-Madison, Madison, WI 53705, USA; William S. Middleton Memorial Veterans Administration Hospital, Madison, WI 53705, USA
236
days
Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis
AuthorsShan Li; Juan Li; Wenjing Shi; Ziyan Nie; Shasha Zhang; Xue Ding; Jun Hu; Peiqiang Li; Xiaodong Xie
AffiliationsSchool of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu 730000, China; Department of Laboratory Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, China; Gansu Key Laboratory of Genetic Study of Hematopathy, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, China
151
days
The lncRNA, CyKILRb acts as a ceRNA for tumor suppressive microRNA to augment oncogenic phenotype via induction of PIK3R2/PI3K/AKT axis
AuthorsXiujie Xie; H. Patrick Macknight; Barbara Dziegielewska; Amy L. Lu; Ngoc Thanh Vu; Charles E. Chalfant
AffiliationsDepartment of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA 22903, USA; Research Service, Central Virginia Veterans Affairs Health Care System, Richmond, VA 23249, USA; Department of Applied Chemistry, School of Biotechnology, International University, Ho Chi Minh City, Vietnam; Vietnam National University, Ho Chi Minh City, Vietnam; Program in Cancer Biology, University of Virginia NCI Comprehensive Cancer Center, Charlottesville, VA 22903, USA
221
days
An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD
AuthorsAo Dong; Na Li; Xiping Lang; Shunkai Chen; Yifeng Qin; Yuhang Wang; Haisheng Wang; Miaomiao Guo; Aomei Yan; Kai Song; Jingyi Bi; Guiping Ren; Fan Lai; Juan Yang; Yunkun Dang
AffiliationsMOE Key Laboratory for Southwest Microbial Diversity, Yunnan Key Laboratory of Cell Metabolism and Diseases, Center for Life Science, School of Life Sciences, Yunnan University, Kunming 650500, China; SicaGene BioScience Co., Ltd., Building 6, 20 Pingan Road, Mentougou District, Beijing 102300, China; Key Laboratory of Organic Chemistry, Institute of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, China; Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China; Southwest United Graduate School, Kunming, China; Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province 650032, China
103
days
Quantum molecular resonance and secretome synergistically unlocks a protective ceRNA axis in the human retinal pigment epithelium
AuthorsSimona Alibrandi; Domenico Mordà; Concetta Scimone; Angela D’Ascola; Federica Aliquò; Giorgia Abate; Gianantonio Pozzato; Sergio Zaccaria Scalinci; Rosalia D’Angelo; Antonina Sidoti; Luigi Donato
AffiliationsDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, Division of Medical Biotechnologies and Preventive Medicine, University of Messina, 98125 Messina, Italy; Department of Biomolecular Strategies, Genetics and Avant-Garde Therapies, Euro-Mediterranean Institute of Science and Technology (I.E.ME.S.T.), 90139 Palermo, Italy; Department of Veterinary Sciences, University of Messina, 98125 Messina, Italy; Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy; Telea Electronic Engineering Srl, 36066 Sandrigo, Italy; Department of Medical and Surgical Sciences, University of Bologna, 40121 Bologna, Italy; Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale F. Stagno d'Alcontres 31, 98166 Messina, Italy
214
days
Development of an antisense oligonucleotide targeting EFEMP1 in models relevant to macular degeneration
AuthorsWilliam P. Miller; Said Arevalo-Alquichire; Paula Perez-Corredor; Rose Lin; Anil Upreti; Jeysson Sanchez-Suarez; Tim E. Vanderleest; Claudia Marino; Donovan Spencer; Matthew Scribner; Jebgy Vargas; Andres Muriel-Torres; Xinyao Hu; Yvonne Adu-Rutledge; Bryan A. Kaplan; Karim W. Barake; Audrey L. Gunawan; Aruvi Vijikumar; Reeya Shrestha; Anton Lennikov; Leo A. Kim; Joseph F. Arboleda-Velasquez; Andrew Peterson; Sudhir Agrawal; Vinod Vathipadiekal; Carlos Loya; Michael O’Hare
AffiliationsSchepens Eye Research Institute of Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, MA 02114, USA; Department of Neurology, Sealy Institute for Drug Discovery and Mitchell Center for Neurodegenerative Diseases, The University of Texas Medical Branch, Galveston, TX, USA; Mass Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, MA 02114, USA; Aldebaran Therapeutics, Waltham, MA, USA; Alloy Therapeutics, Waltham, MA, USA; Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, UK
216
days
GDF5 modulation of MuSC pool as a potential therapeutic benefit for DMD
AuthorsChristel Gentil; Aly Bourguiba; Amélie Vergnol; Bruno Cadot; Zoheir Guesmia; Lucile Saillard; Pierre Meunier; Bénédicte Hoareau-Coudert; Mégane Lemaitre; Sestina Falcone; Lorenzo Giordani; France Pietri-Rouxel
AffiliationsSorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, 75013 Paris, France; Plateforme de Cytométrie (CyPS), Sorbonne Université, UMS 037 PASS, 75013 Paris, France; Sorbonne Université-UPMC Paris 06-INSERM UMS28-Phénotypage Du Petit Animal-Faculté de Médecine, Paris, France
170
days
Y-RNAs and their fragments reflect kidney injury in diabetic kidney disease
AuthorsQiao Zhao; Yunyi Liang; Rudmer Postma; Jacques M.G.J. Duijs; Juliette A. de Klerk; Leen M. ’t Hart; Joris I. Rotmans; Anton Jan van Zonneveld; Roel Bijkerk
AffiliationsDepartment of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, the Netherlands; Nephrology Department, General Hospital of Northern Theater Command, Shenyang City, China; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days